secwatch.observer — SEC 8-K summary
======================================

Issuer:     Clearside Biomedical, Inc. (CLSDQ)
CIK:        0001539029
Form:       8-K
Filed at:   2024-04-16T23:59:59+00:00
Accession:  0000950170-24-044594
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Clearside Biomedical appoints Anthony S. Gibney to its Board of Directors
-------------------------------------------------------------------------

- Mr. Gibney appointed as a Class III director effective April 15, 2024; term runs through 2025 annual meeting.
- He brings over 25 years biotech experience including Iveric Bio, Achillion, and Leerink Partners.
- Received an option to purchase 45,000 shares of CLSD common stock vesting over 36 months.
- Entitled to $40,000 annual retainer plus additional annual option grants for continuous service.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1539029/000095017024044594/0000950170-24-044594-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1539029/000095017024044594/clsd-20240415.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-044594

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer